Constipation

Published on 10/02/2015 by admin

Filed under Emergency Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 1 (1 votes)

This article have been viewed 1509 times

37 Constipation

Perspective

Constipation is a common symptom causing visits to the emergency department (ED) and rarely requires extensive ED evaluation or hospital admission. Associated signs and symptoms determine the optimal ED approach to evaluation and management. Although the majority of these patients will have chronic functional constipation, identifying which patients have serious underlying pathology is of greatest concern for the emergency physician (EP).

Epidemiology

Constipation is common at all ages, with the reported prevalence ranging from 2% to 27%,1 depending on the definition used. Prevalence is higher in women than in men (approximately 2 : 1), perhaps related to an increased prevalence of pelvic floor dyssynergy in women.2 Prevalence is higher in the elderly: in those older than 84 years, self-reported rates are 25.7% in men and 34.1% in women,3 and up to 74% of elderly nursing home residents are taking laxatives daily.2 The condition is much less common in populations with non-Western diets containing more bulk. Although many people do not seek medical attention for their constipation, this condition is estimated to result in almost $7 billion in medical costs in the United States each year.3

Pathophysiology

Constipation is often multifactorial, with disordered movement of stool through the colon and anorectum. Oral intake, hydration, and general mobility affect colonic function. Numerous anatomic and structural entities, gastrointestinal (GI) disorders, medications, and systemic disorders may secondarily lead to constipation (Boxes 37.1 to 37.4) by altering intraluminal contents, fluid balance, intestinal contractions, or neuromuscular coordination. However, the majority of patients have primary chronic functional constipation that falls into one or more of three categories. Many actually have normal intestinal transit time; their constipation is perceptual and related to habits. Others have slow transit times because of overall colonic slowing (pancolonic inertia) or sigmoid spasm (left colonic hypermotility with uncoordinated segmental contractions and poor propulsion). An important but underrecognized group has pelvic floor dyssynergy (obstructive defecation), an acquired behavioral condition that begins with chronically ignoring the urge to defecate. Disordered defecatory function of the pelvic floor muscles and sphincters eventually produces difficulty expelling stool, even if soft. Hormonal contributions are unclear, but constipation is common in pregnancy4 and before menstruation. Contrary to past thinking, chronic laxative abuse does not cause chronic constipation.5 High rates in the elderly are not due to aging itself but to concomitant conditions or medications.6

Presenting Signs and Symptoms

To the physician, the term constipation usually means a reduced frequency of bowel movements (less than three per week in Western culture) or difficult passage of hard stool (or both). To the patient, constipation may mean frequency reduced to less than daily, decreased volume per defecation, passage of hard stool, difficulty passing stool, straining, a feeling of incomplete evacuation, abdominal pain, rectal pain, inability to defecate when desired or without a laxative, abdominal distention or bloating, or any combination thereof. An individual’s perception of what is “normal” is also highly variable and often deeply ingrained, with many convinced that less than one stool per day is a serious problem.

A formal consensus definition is therefore used by gastroenterologists, and the label of chronic functional constipation requires two or more of the following occurring for at least 3 months of the past year: straining for at least 25% of defecations, lumpy or hard stools in 25% or more of defecations, sensation of incomplete evacuation in 25% or more of defecations, sensation of anorectal obstruction or blockage in 25% or more of defecations, manual maneuvers to facilitate passage (digital evacuation or support of the pelvic floor) in 25% or more of defecations, or fewer than three defecations per week.7 A practical pediatric definition is delay or difficulty in defecation present for 2 or more weeks.8

Abdominal bloating and mild diffuse abdominal discomfort are common with functional constipation. Vomiting, severe pain, fever, and GI bleeding indicate more serious causes. Passage of hard stool may produce rectal bleeding, but the quantity should be small. Straining may cause dizziness, a vagal reaction, or both.

With functional constipation, the findings on physical examination should be normal other than palpation of abundant stool on abdominal or rectal examination (or both) and perhaps mild discomfort on abdominal palpation.

Differential Diagnosis and Medical Decision Making

Constipation is a symptom that may be secondary to a myriad of other causes, but it most often represents chronic functional constipation. Boxes 37.1 to 37.4 list the various causes of secondary constipation—GI and systemic disorders, medications, and additional causes in children.

Evaluation in the ED is focused on distinguishing potentially serious cases that warrant immediate inpatient care via a careful history (what the patient means by the term constipation, bowel history, and potential underlying causes, especially medications) and examination (particularly vital signs, abdominal examination, perirectal inspection, and rectal examination). With chronic symptoms, it is important to ask what precipitated today’s ED visit. New-onset constipation suggests new medications, sudden lifestyle changes, anal sphincter spasm and pain, or more serious conditions, including mass lesions and intestinal obstruction.

Signs of obvious systemic abnormalities, volume depletion, infection, peritonitis, ileus, and obstruction are important to identify early. In patients with functional constipation, abdominal examination should find only mild discomfort at most. Excessive colonic stool can often be palpated. Unlike a solid mass, stool should indent somewhat on palpation. Serial abdominal examinations are invaluable in uncertain cases. Fecal impaction, abnormal sphincter tone, and potential sources of bleeding or rectal pain may be detected on perirectal and rectal examination. Anoscopy (with topical anesthetic applied before the examination) is appropriate in patients with rectal complaints.

Red flags for a more serious acute condition include severe pain, vomiting, fever, GI bleeding, acute onset, persistent tachycardia, hypotension, and peritoneal signs. Elderly patients warrant higher clinical suspicion for worrisome causes, particularly if febrile, and extraabdominal infections may be manifested as general failure to thrive or constipation. In adults older than 50 years, anemia, weight loss, acute change in bowel habits, GI bleeding, and a family history of colon cancer or inflammatory bowel syndrome (IBS) are “alarm” findings of possible underlying malignancy or IBS and warrant early referral for endoscopy or radiographic studies.9

In ED patients in whom clinical suspicion for serious pathology is low, appropriate studies are limited to basic chemistry panels (including calcium) and a complete blood count. Suspicion of an obstruction, fecal impaction, ileus, megacolon, or perforation should prompt plain abdominal films (flat and upright); serial plain films may assist in diagnosing early obstruction when the initial evaluation is unclear. Emergency computed tomography (CT) scans are appropriately limited to situations suggesting obstruction, intraabdominal abscess, complicated hernia, or diverticulitis. Early surgical consultation is appropriate for probable obstruction or peritonitis.

Considerations by Patient Age

Considerations by Cause

Treatment

Intravenous fluid repletion with correction of electrolyte disturbances is the mainstay of initial management in sicker patients. Suspected mechanical obstruction or perforation warrants immediate surgical consultation and admission. Intravenous fluids and analgesics are warranted, whereas laxatives are contraindicated. Patients with nausea or vomiting need antiemetics. Those with obstruction or ileus may benefit from nasogastric suctioning, plus an intravenous gastric acid blocker to prevent metabolic alkalosis. Large bowel obstruction may require early colonoscopy with decompression.

Patients with pseudoobstruction warrant inpatient care unless they are known to have chronic intermittent pseudoobstruction with only a mild exacerbation of their constipation. For acute megacolon from colonic pseudoobstruction, the prokinetic neostigmine is a standard therapy, but this is usually ordered by the gastroenterologist and followed by decompressive colonoscopy.14 Prokinetic agents are contraindicated in patients with obstruction, perforation, or peritonitis.

Fecal impaction may complicate long-standing constipation, particularly in nursing home residents or opiate users. Initial cleansing in milder cases may be done safely with large-volume oral polyethylene glycol (PEG), which is done in many nursing homes. Others usually require initial digital disimpaction, as discussed later, followed by PEG cleansing and then a maintenance plan. ED time constraints may prompt admission to an observation unit for initial cleansing.

For patients with uncomplicated constipation, the starting point in the ED focuses on volume repletion and electrolyte correction as needed, followed by a bowel regimen appropriate for the level of fecal loading, plus any treatment specific to contributing causes. The EP should also consider whether pelvic floor dyssynergy is a probable component that the patient should discuss with a primary care physician. The clinician should keep in mind the problem that bothers the patient the most (infrequency, straining, or hard stool) and that the patient’s expectations often include prescription “cures” and an unrealistic goal of rapidly becoming “normal.” Patient education is vital.

The plan for bowel care includes:

Most patients are sent home with a management plan and education, but initial cleansing in the ED or observation unit and serial reexamination should be considered if a suspicion remains about a more serious underlying cause or if the patient may not be able to perform the initial steps (or has no reliable caretaker to do so). A myriad of products are available for constipation (Table 37.1).15 Selection should focus on efficacy, safety, and cost, as well as patient preference.

see Table 37.1 Therapeutic Agents for Constipation in Adults, online at www.expertconsult.com

If ED cleansing is necessary, time constraints prompt the use of stimulant laxatives per rectum, either suppositories (glycerin or bisacodyl) or enemas (tap water or phosphate). A topical anesthetic gel will decrease defecatory pain. Digital disimpaction may speed the process but is generally reserved as a last resort. Digital stimulation (several gentle rotations of a gloved, well-lubricated finger within the rectum) may loosen up fecal concretions and stimulate spontaneous defecation; this may be repeated after a 10-minute pause. If no response is seen, the lumps will need to be gently broken up and removed by finger. In spinal cord or elderly patients, the pulse and blood pressure should be monitored during disimpaction for changes secondary to vagal stimulation or autonomic dysreflexia.16

Outpatient treatment should start with osmotic laxatives such as PEG to be taken at home or just bulk agents, prune juice, or dried prunes if the constipation is mild. A stimulant laxative (e.g., glycerin suppository) is to be taken if the simpler treatment fails.17 Strong evidence supports the use of PEG, moderate evidence supports lactulose and psyllium, and little evidence exists for or against other agents.18,19 In the elderly, all laxative categories may cause some bloating, flatulence, or abdominal pain.20

Bulk agents are the first-line maintenance treatment of functional constipation with a normal or slow transit time. Bulk agents increase fecal water content and stool volume, reduce transit time, and improve stool consistency. Bran fiber (25 g/day) in foods may be adequate and must be accompanied by increased fluid intake. Fiber may cause increased gas (bloating, flatulence), but this is less likely if intake is increased gradually.

The stool softeners sodium and calcium docusate decrease surface tension and allow stool to mix with fluids but do not induce defecation. These agents are not good for long-term use because of tachyphylaxis, but they are very useful in the short term while taking constipating medications (e.g., opiates) or for patients who should avoid straining.

Lubricant agents penetrate and soften stool. Mineral oil can be given orally or by enema. Because it may be aspirated and cause lipoid pneumonia, it should not be used in patients with esophageal dysmotility, dysphagia, or gastroesophageal reflux.

Osmotic laxatives are hyperosmotic agents that generally provide excellent relief of constipation and may be used in small doses for the long term if needed. A large volume of PEG is used for procedural preparation or initial cleansing of large fecal loads, but most cases of constipation respond to one packet (17 g) daily, which may be continued as a maintenance dosage; PEG without electrolytes is more palatable. Lactulose and sorbitol (given orally or as enemas) are nonabsorbable sugars degraded by colonic bacteria to acids that increase stool acidity and osmolarity and thereby lead to accumulation of fluid in the colon to speed defecation. Lactulose is excellent for long-term use in small doses but should be avoided in most diabetics. Corn syrup is used in infants.8

Stimulant laxatives are the most rapidly acting agents and are taken either orally or per rectum (faster). They are likely to cause some cramping. Saline cathartics exert osmotic effects to increase intraluminal water content. Though relatively nonabsorbable, magnesium preparations should be avoided in patients with renal failure because they may cause hypermagnesemia or fluid retention. Castor oil is hydrolyzed to ricinoleic acid, which stimulates intestinal secretion and motility. Bisacodyl causes fluid accumulation and increased motor activity. Anthraquinones (cascara, senna) are converted to active states by intestinal microorganisms and increase fluid and electrolyte accumulation in the distal end of the bowel; melanosis coli may result from long-term use but is benign and reversible. Stimulants are not generally recommended for frequent long-term use.

General measures often help:

Dietary fiber sources are primarily bran and grains, but dried fruits, pulp-rich citrus juices, many vegetables, and even popcorn contribute fiber. Retraining bowel habits may help; patients must allow an unhurried time (20 minutes or so) to use the toilet, especially after a meal (breakfast is ideal) to take advantage of the gastrocolic reflex, and they should respond to the urge to defecate. Contributing medications require careful review of their necessity, planned duration of use, and alternatives. For drugs that must be continued, increased fiber and the addition of stool softeners may suffice, with daily PEG or lactulose added if needed. Bulk agents may affect the bioavailability of some drugs. The EP must communicate clearly to the patient that the constipation is a side effect of medications that needs to be discussed with the primary care provider.

Concomitant treatment of underlying causes and contributors is essential. Treatment of painful rectal problems improves overall bowel function. Although they are not generally prescribed in an ED setting, other treatments are available.19 Lubiprostone is a bicyclic fatty acid that activates GI chloride channels to increase intestinal fluid secretion and effectively treats chronic functional constipation.21 Even in the elderly, pelvic floor dyssynergy may respond well to physical therapy, behavioral modification, and biofeedback training.22,23 Surgery may relieve specific defects, such as rectoceles, and is the mainstay for treatment of Hirschsprung disease.9

Follow-Up Care and Patient Education

Patient Education

Patient education is crucial. Patients are often frightened and disturbed by symptoms that the physician may take lightly; reassurance and discussion are invaluable. As appropriate, the EP should explain that cancer or other serious disease is highly unlikely but that compliance with follow-up remains essential. The patient should be taught about “normal” bowel function, general measures to improve symptoms, and reasonable goals. The EP and nurse must also ensure that patients know how to use the items recommended, especially suppositories or enemas.24

image Patient Teaching Tips

Functional Constipation

References

1 Lembo AJ, Camilleri M. Chronic constipation. N Engl J Med. 2003;349:1360–1368.

2 Brandt LJ, Prather CM, Quigley EM, et al. Systematic review on the management of chronic constipation in North America. Am J Gastroenterol. 2005;100(Suppl 1):S5–21.

3 Crane SJ. Chronic gastrointestinal symptoms in the elderly. Clin Geriatr Med. 2007;23:721–734.

4 Wald A. Constipation, diarrhea, and symptomatic hemorrhoids during pregnancy. Gastroenterol Clin North Am. 2003;32:309.

5 Wald A. Is chronic use of stimulant laxatives harmful to the colon? J Clin Gastroenterol. 2003;36:386–389.

6 World Gastroenterology Organization. Practice guidelines: constipation. Available at guidelines@worldgastroenterology.org, 2007.

7 Lembo AJ, Ullman SP. Constipation. 9th ed. Feldman M, Friedman LS, Brandt LJ, eds. Sleisinger and Fordtran’s gastrointestinal and liver disease. Philadelphia: Saunders; 2010;vol 1:259–279.

8 Constipation Guideline Committee of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Evaluation and treatment of constipation in infants and children: recommendations from the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2006;43(3):e1–13.

9 Ternent CA, Bastawrous AL, Morin NA, et al. Practice parameters for the evaluation and management of constipation. Dis Colon Rectum. 2007;50:2013.

10 Youssef NN, Sanders L, Di Lorenzo C. Adolescent constipation: evaluation and management. Adolesc Med Clin. 2004;15:37–52.

11 Creason N, Sparks D. Fecal impaction: a review. Nurs Diagn. 2000;11:15–21.

12 Laine C, Goldmann D, Wilson JF. In the clinic: irritable bowel syndrome. Ann Intern Med. 2007;147:ITC7-1–ITC-16.

13 Schoenfeld P. Efficacy of current drug therapies in irritable bowel syndrome: what works and does not work. Gastroenterol Clin North Am. 2005;34:319–335.

14 Batke M, Cappell MS. Adynamic ileus and acute colonic pseudo-obstruction. Med Clin North Am. 2008;92:649–670.

15 Singh S, Rao SS. Pharmacologic management of chronic constipation. Gastroenterol Clin North Am. 2010;39:509–527.

16 Kyle G, Prunn P, Oliver H. A procedure for the digital removal of faeces. Nurs Stand. 2005;19:33–39.

17 Rao SS. Constipation: evaluation and treatment. Gastroenterol Clin North Am. 2003;32:659–683.

18 Ramkumar D, Rao SS. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol. 2005;100:936–971.

19 American College of Gastroenterology Constipation Task Force. An evidence-based approach to the management of chronic constipation in North America. Am J Gastroenterol. 2005;100:4.

20 Zarowitz BJ. Pharmacologic consideration of commonly used gastrointestinal drugs in the elderly. Gastroenterol Clin North Am. 2009;38:447–562.

21 Johansen JF, Ueno R. Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation. Aliment Pharmacol Ther. 2007;25:1351–1361.

22 Rao SS. Dyssynergic defecation and biofeedback therapy. Gastroenterol Clin North Am. 2008;37:569–586.

23 Bouras EP, Tangalos EG. Chronic constipation in the elderly. Gastroenterol Clin North Am. 2009;38:463.

24 MD Consult. Patient education: laxatives, OTC products for constipation (2008); constipation (2008); constipation, management of (2011). Mdconsult.com.